The company works to develop psychedelic drugs that could be used in the treatment of PTSD. Transcend will use the funding to launch clinical trials, according to a Feb. 23 Transcend news release.
Alpha Wave Global and Integrated Investment Partners led the financing round, bringing the company’s total raised to $42 million.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
